Evidence map›Paper›PMID 15517334›Full record

ArticleHistochemistry and cell biology2004

Immunolocalization of protein 4.1B/DAL-1 during neoplastic transformation of mouse and human intestinal epithelium.

Nobuhiko Ohno, Nobuo Terada, Shin-ichi Murata, Hisashi Yamakawa, Irene F Newsham, Ryohei Katoh, Osamu Ohara, Shinichi Ohno

Abstract read
PubMed Publisher
In one paragraph

Article in Histochemistry and cell biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. 4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  6. Article
  7. Article
  8. Tumor suppressor role of protein 4.1B/DAL-1.Cellular and molecular life sciences : CMLS · 2014
    Review
  9. Article
  10. Article
  11. [Expressions and clinical significances of TSLC1 and 4.1B in non-small cell lung cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2010
    Article
  12. Protein 4.1B suppresses prostate cancer progression and metastasis.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  13. Review
  14. Article
  15. Review
  16. Protein 4.1 G localizes in rodent microglia.Histochemistry and cell biology · 2005
    Article
  17. Article
  18. News and views in Histochemistry and Cell Biology.Histochemistry and cell biology · 2004
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Nobuhiko OhnoDepartment of Anatomy, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Tamaho, 409-3898 Yamanashi, Japan. sohno@yamanashi.ac.jp
Nobuo Terada
Shin-ichi Murata
Hisashi Yamakawa
Irene F Newsham
Ryohei Katoh
Osamu Ohara
Shinichi Ohno
University of Yamanashi · JPKazusa DNA Research Institute · JPHenry Ford Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, we have reported that the protein 4.1B immunolocalization occurred only in matured columnar epithelial cells of normal rat intestines. This finding suggested that protein 4.1B expression could be examined for a possible change during neoplastic transformation of the intestinal mucosa. In the present study, we first present the distribution of mouse protein 4.1B in normal intestinal epithelial cells and tumor cells using the adenomatous polyposis coli (Apc) mutant mouse model. A low level of protein 4.1B expression coincided with the phenotypic transition to carcinoma. To examine the protein 4.1B expression in human intestinal mucosa, we used another antibody against an isoform of the human protein 4.1B, DAL-1 (differentially expressed adenocarcinoma of the lung). Human DAL-1 was also expressed in matured epithelial cells in human colons, with a definite expression gradient along the crypt axis. In human colorectal cancer cells, however, DAL-1 expression was not detected. These results suggest that mouse protein 4.1B and human DAL-1 might have a striking analogy of functions, which may be integrally involved in epithelial proliferation. We propose that loss of protein 4.1B/DAL-1 expression might be a marker of intestinal tumors, indicative of a tumor suppressor function in the intestinal mucosa.

Indexed as

Animalsbeta CateninBlotting, WesternCell Transformation, NeoplasticColonColorectal NeoplasmsCytoskeletal ProteinsHumansImmunohistochemistryIntestinal MucosaIntestinal NeoplasmsMembrane ProteinsMiceMicrofilament ProteinsTrans-ActivatorsTumor Suppressor Proteinsbeta CateninCTNNB1 protein, humanCTNNB1 protein, mouseCytoskeletal ProteinsEPB41L3 protein, humanEpb41l3 protein, mouseMembrane ProteinsMicrofilament ProteinsTrans-ActivatorsTumor Suppressor Proteins

Identifiers

PMID15517334
OpenAlexW2128270828

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.